Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Glaxf crawled time : 13:30 save search
Sports Nutrition Market in Europe - 40% of Growth to Originate from the UK| Non-Protein Sports Nutrition Segment to be Significant for Revenue Generation |17000+ Technavio Reports
Published: 2022-03-14 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 9.61%
H: 0.0%
C: -0.57%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
europe nutrition origin report growth
Benign Prostatic Hyperplasia Therapeutics Market to Reach $9.39 Bn, Globally, by 2030 at 5.0% CAGR: Allied Market Research
Published: 2022-02-22 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.57%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.84%
H: 0.49%
C: 0.09%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.61%
H: 1.05%
C: -0.86%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.93%
H: 0.77%
C: 0.12%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: 0.83%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
research therapeutics
Dermatologicals Market to Reach $59.30 Bn, Globally, by 2030 at 11.50% CAGR: AMR
Published: 2022-02-21 (Crawled : 13:30) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
als dermatological derm
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG A | $130.9 -3.12% 0.0% 4.5M
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $5.42 1.12% 1.11% 1.1M
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
space spac
Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.36%
H: 0.46%
C: 0.46%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -4.59%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
covid-19 treatment europe granted covid authorization grant
GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting
Published: 2021-11-18 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.25%
H: 3.09%
C: -0.45%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.66%
H: 0.24%
C: -0.12%
trial